Updated on 8 August 2012
Interview: Dr Dan Kaiser, VP and CTO, Greatbatch
Medical Technology manufacturers are getting cost-conscious and so are the buyers, especially in some parts of Asia. International life science companies have been evaluating ways to meet the low price tag demand of the Asian market without compromising on quality. US-based medical technology provider Greatbatch is on its toes to find a solution.
Greatbatch, which provides components to medtech companies, such as Boston Scientific, J&J, and Medtronics, is exploring potentials in the medical devices markets in India and China. It also has plans to establish a R&D center in Singapore, which will be a continuation of its medical device strategy to engage in emerging healthcare markets.
The idea is to bring innovation in the designing of products that will eventually cut down the cost. In an interview with BioSpectrum Asia, Dr Dan Kaiser, vice president and chief technology officer, Greatbatch, shares the company's plan to venture into the Asian market. Here are the excerpts:
You have decided to enter the Asian market. What will be your next step?
Our whole idea is to build on the innovation pipeline and bring cost-efficient medical devices to Asia without compromising on quality standards. We have identified India and China as our target markets, and hence the next step is to understand the requirements of the region and accordingly develop medical devices. Greatbatch has decided to build a medical devices R&D center in Singapore that will aim at designing low-cost medical technology for Asian markets.